questionsmedicales.fr
Système nerveux
Système nerveux central
Encéphale
Prosencéphale
Télencéphale
Cerveau
Noyaux gris centraux
Noyaux gris centraux : Questions médicales fréquentes
Termes MeSH sélectionnés :
Internet-Based Intervention
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Noyaux gris centraux : Questions médicales les plus fréquentes",
"headline": "Noyaux gris centraux : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Noyaux gris centraux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-25",
"dateModified": "2025-02-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Noyaux gris centraux"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Cerveau",
"url": "https://questionsmedicales.fr/mesh/D054022",
"about": {
"@type": "MedicalCondition",
"name": "Cerveau",
"code": {
"@type": "MedicalCode",
"code": "D054022",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Amygdale (système limbique)",
"alternateName": "Amygdala",
"url": "https://questionsmedicales.fr/mesh/D000679",
"about": {
"@type": "MedicalCondition",
"name": "Amygdale (système limbique)",
"code": {
"@type": "MedicalCode",
"code": "D000679",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.152"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Groupe nucléaire basolatéral",
"alternateName": "Basolateral Nuclear Complex",
"url": "https://questionsmedicales.fr/mesh/D066272",
"about": {
"@type": "MedicalCondition",
"name": "Groupe nucléaire basolatéral",
"code": {
"@type": "MedicalCode",
"code": "D066272",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.152.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Noyau central de l'amygdale",
"alternateName": "Central Amygdaloid Nucleus",
"url": "https://questionsmedicales.fr/mesh/D066274",
"about": {
"@type": "MedicalCondition",
"name": "Noyau central de l'amygdale",
"code": {
"@type": "MedicalCode",
"code": "D066274",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.152.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Groupe nucléaire cortico-médial",
"alternateName": "Corticomedial Nuclear Complex",
"url": "https://questionsmedicales.fr/mesh/D066276",
"about": {
"@type": "MedicalCondition",
"name": "Groupe nucléaire cortico-médial",
"code": {
"@type": "MedicalCode",
"code": "D066276",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.152.875"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Claustrum",
"alternateName": "Claustrum",
"url": "https://questionsmedicales.fr/mesh/D000079482",
"about": {
"@type": "MedicalCondition",
"name": "Claustrum",
"code": {
"@type": "MedicalCode",
"code": "D000079482",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.320"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Corps strié",
"alternateName": "Corpus Striatum",
"url": "https://questionsmedicales.fr/mesh/D003342",
"about": {
"@type": "MedicalCondition",
"name": "Corps strié",
"code": {
"@type": "MedicalCode",
"code": "D003342",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.487"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Globus pallidus",
"alternateName": "Globus Pallidus",
"url": "https://questionsmedicales.fr/mesh/D005917",
"about": {
"@type": "MedicalCondition",
"name": "Globus pallidus",
"code": {
"@type": "MedicalCode",
"code": "D005917",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.487.397"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Néostriatum",
"alternateName": "Neostriatum",
"url": "https://questionsmedicales.fr/mesh/D017072",
"about": {
"@type": "MedicalCondition",
"name": "Néostriatum",
"code": {
"@type": "MedicalCode",
"code": "D017072",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.487.550"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Noyau caudé",
"alternateName": "Caudate Nucleus",
"url": "https://questionsmedicales.fr/mesh/D002421",
"about": {
"@type": "MedicalCondition",
"name": "Noyau caudé",
"code": {
"@type": "MedicalCode",
"code": "D002421",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.487.550.184"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Putamen",
"alternateName": "Putamen",
"url": "https://questionsmedicales.fr/mesh/D011699",
"about": {
"@type": "MedicalCondition",
"name": "Putamen",
"code": {
"@type": "MedicalCode",
"code": "D011699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.487.550.784"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Noyau caudé",
"alternateName": "Caudate Nucleus",
"url": "https://questionsmedicales.fr/mesh/D002421",
"about": {
"@type": "MedicalCondition",
"name": "Noyau caudé",
"code": {
"@type": "MedicalCode",
"code": "D002421",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.487.550.184"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Putamen",
"alternateName": "Putamen",
"url": "https://questionsmedicales.fr/mesh/D011699",
"about": {
"@type": "MedicalCondition",
"name": "Putamen",
"code": {
"@type": "MedicalCode",
"code": "D011699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.487.550.784"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Striatum ventral",
"alternateName": "Ventral Striatum",
"url": "https://questionsmedicales.fr/mesh/D066328",
"about": {
"@type": "MedicalCondition",
"name": "Striatum ventral",
"code": {
"@type": "MedicalCode",
"code": "D066328",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.487.775"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Noyau accumbens",
"alternateName": "Nucleus Accumbens",
"url": "https://questionsmedicales.fr/mesh/D009714",
"about": {
"@type": "MedicalCondition",
"name": "Noyau accumbens",
"code": {
"@type": "MedicalCode",
"code": "D009714",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.487.775.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Noyau accumbens",
"alternateName": "Nucleus Accumbens",
"url": "https://questionsmedicales.fr/mesh/D009714",
"about": {
"@type": "MedicalCondition",
"name": "Noyau accumbens",
"code": {
"@type": "MedicalCode",
"code": "D009714",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.487.775.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Substance innominée",
"alternateName": "Substantia Innominata",
"url": "https://questionsmedicales.fr/mesh/D013377",
"about": {
"@type": "MedicalCondition",
"name": "Substance innominée",
"code": {
"@type": "MedicalCode",
"code": "D013377",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.880"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Noyau basal de Meynert",
"alternateName": "Basal Nucleus of Meynert",
"url": "https://questionsmedicales.fr/mesh/D020532",
"about": {
"@type": "MedicalCondition",
"name": "Noyau basal de Meynert",
"code": {
"@type": "MedicalCode",
"code": "D020532",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.249.880.100"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Noyaux gris centraux",
"alternateName": "Basal Ganglia",
"code": {
"@type": "MedicalCode",
"code": "D001479",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Clara Rodriguez-Sabate",
"url": "https://questionsmedicales.fr/author/Clara%20Rodriguez-Sabate",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Neurobiology and Experimental Neurology, Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, Tenerife, Canary Islands, Spain."
}
},
{
"@type": "Person",
"name": "Ingrid Morales",
"url": "https://questionsmedicales.fr/author/Ingrid%20Morales",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Neurobiology and Experimental Neurology, Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, Tenerife, Canary Islands, Spain."
}
},
{
"@type": "Person",
"name": "Manuel Rodriguez",
"url": "https://questionsmedicales.fr/author/Manuel%20Rodriguez",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Neurobiology and Experimental Neurology, Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, Tenerife, Canary Islands, Spain. mrdiaz@ull.edu.es."
}
},
{
"@type": "Person",
"name": "Sachin Manjunath",
"url": "https://questionsmedicales.fr/author/Sachin%20Manjunath",
"affiliation": {
"@type": "Organization",
"name": "Aster Medcity, Kochi, India."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Internet-Based Versus Face-to-Face Cognitive-Behavioral Therapy for Social Anxiety Disorder: A Randomized Control Trial.",
"datePublished": "2023-09-04",
"url": "https://questionsmedicales.fr/article/38670666",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.beth.2023.08.005"
}
},
{
"@type": "ScholarlyArticle",
"name": "Factorial Trial to Optimize an Internet-Delivered Intervention for Sexual Health After Breast Cancer: Protocol for the WF-2202 Sexual Health and Intimacy Enhancement (SHINE) Trial.",
"datePublished": "2024-08-19",
"url": "https://questionsmedicales.fr/article/39159450",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2196/57781"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Acceptance and use of web-based interventions for alcohol abstinence].",
"datePublished": "2022-09-13",
"url": "https://questionsmedicales.fr/article/36098784",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00115-022-01385-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Internet of Things-Based Home Respiratory Muscle Training for Patients with Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial.",
"datePublished": "2024-05-22",
"url": "https://questionsmedicales.fr/article/38800522",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2147/COPD.S454804"
}
},
{
"@type": "ScholarlyArticle",
"name": "Is Therapist Support Needed? Comparing Therapist- and Self-Guided Internet-Based CBT for Somatic Symptom Distress (iSOMA) in Emerging Adults.",
"datePublished": "2022-07-03",
"url": "https://questionsmedicales.fr/article/36229117",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.beth.2022.06.006"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009420"
},
{
"@type": "ListItem",
"position": 3,
"name": "Système nerveux central",
"item": "https://questionsmedicales.fr/mesh/D002490"
},
{
"@type": "ListItem",
"position": 4,
"name": "Encéphale",
"item": "https://questionsmedicales.fr/mesh/D001921"
},
{
"@type": "ListItem",
"position": 5,
"name": "Prosencéphale",
"item": "https://questionsmedicales.fr/mesh/D016548"
},
{
"@type": "ListItem",
"position": 6,
"name": "Télencéphale",
"item": "https://questionsmedicales.fr/mesh/D013687"
},
{
"@type": "ListItem",
"position": 7,
"name": "Cerveau",
"item": "https://questionsmedicales.fr/mesh/D054022"
},
{
"@type": "ListItem",
"position": 8,
"name": "Noyaux gris centraux",
"item": "https://questionsmedicales.fr/mesh/D001479"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Noyaux gris centraux - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Noyaux gris centraux",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Noyaux gris centraux",
"description": "Comment diagnostiquer une dysfonction des noyaux gris centraux ?\nQuels tests sont utilisés pour évaluer les noyaux gris centraux ?\nQuels signes cliniques indiquent une atteinte des noyaux gris centraux ?\nLes tests génétiques sont-ils utiles pour le diagnostic ?\nQuelle est l'importance de l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Internet-Based+Intervention&page=7#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Noyaux gris centraux",
"description": "Quels sont les symptômes courants des troubles des noyaux gris centraux ?\nComment se manifestent les troubles de la coordination ?\nLes troubles de la parole sont-ils liés aux noyaux gris centraux ?\nLes changements d'humeur peuvent-ils être un symptôme ?\nQuelles sont les manifestations de la rigidité musculaire ?",
"url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Internet-Based+Intervention&page=7#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Noyaux gris centraux",
"description": "Peut-on prévenir les troubles des noyaux gris centraux ?\nQuel rôle joue l'alimentation dans la prévention ?\nLe contrôle du stress peut-il aider à prévenir ces troubles ?\nL'éducation sur les symptômes est-elle importante ?\nLes activités cognitives peuvent-elles prévenir les troubles ?",
"url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Internet-Based+Intervention&page=7#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Noyaux gris centraux",
"description": "Quels traitements sont disponibles pour les troubles des noyaux gris centraux ?\nLes médicaments peuvent-ils soulager les symptômes ?\nQuand la chirurgie est-elle envisagée ?\nLa thérapie physique est-elle bénéfique ?\nQuels sont les effets des thérapies complémentaires ?",
"url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Internet-Based+Intervention&page=7#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Noyaux gris centraux",
"description": "Quelles complications peuvent survenir avec ces troubles ?\nLes troubles cognitifs sont-ils une complication fréquente ?\nComment les troubles de la marche peuvent-ils affecter la vie quotidienne ?\nLes complications psychologiques sont-elles possibles ?\nLes complications peuvent-elles affecter la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Internet-Based+Intervention&page=7#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Noyaux gris centraux",
"description": "Quels sont les facteurs de risque pour les troubles des noyaux gris centraux ?\nLe mode de vie influence-t-il le risque ?\nLes traumatismes crâniens sont-ils un facteur de risque ?\nLes maladies auto-immunes peuvent-elles jouer un rôle ?\nL'exposition à des toxines est-elle un risque ?",
"url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Internet-Based+Intervention&page=7#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des noyaux gris centraux ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic repose sur l'examen neurologique, l'imagerie cérébrale et l'historique médical."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les noyaux gris centraux ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'IRM, le scanner et des évaluations fonctionnelles spécifiques."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une atteinte des noyaux gris centraux ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des tremblements, une rigidité musculaire et des troubles de la coordination."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent aider à identifier des maladies héréditaires affectant les noyaux gris centraux."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier des antécédents familiaux ou des symptômes précurseurs."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des troubles des noyaux gris centraux ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des mouvements involontaires, des troubles de l'équilibre et de la posture."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les troubles de la coordination ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils se manifestent par des difficultés à exécuter des mouvements précis et fluides."
}
},
{
"@type": "Question",
"name": "Les troubles de la parole sont-ils liés aux noyaux gris centraux ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de la parole peuvent survenir en raison de dysfonctionnements dans ces structures."
}
},
{
"@type": "Question",
"name": "Les changements d'humeur peuvent-ils être un symptôme ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des changements d'humeur et des troubles cognitifs peuvent être associés à ces troubles."
}
},
{
"@type": "Question",
"name": "Quelles sont les manifestations de la rigidité musculaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "La rigidité musculaire se traduit par une résistance accrue aux mouvements passifs des membres."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles des noyaux gris centraux ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines mesures de style de vie, comme l'exercice régulier, peuvent réduire les risques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'alimentation dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée riche en antioxydants peut contribuer à la santé cérébrale."
}
},
{
"@type": "Question",
"name": "Le contrôle du stress peut-il aider à prévenir ces troubles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gestion du stress peut réduire le risque de troubles neurologiques."
}
},
{
"@type": "Question",
"name": "L'éducation sur les symptômes est-elle importante ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une éducation précoce sur les symptômes peut favoriser un diagnostic rapide."
}
},
{
"@type": "Question",
"name": "Les activités cognitives peuvent-elles prévenir les troubles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les activités cognitives stimulantes peuvent aider à maintenir la santé cérébrale."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les troubles des noyaux gris centraux ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments, la thérapie physique et, dans certains cas, la chirurgie."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils soulager les symptômes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments comme les anticholinergiques et les dopaminergiques peuvent aider."
}
},
{
"@type": "Question",
"name": "Quand la chirurgie est-elle envisagée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est envisagée lorsque les traitements médicamenteux ne sont pas efficaces."
}
},
{
"@type": "Question",
"name": "La thérapie physique est-elle bénéfique ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle aide à améliorer la mobilité et à réduire les symptômes moteurs."
}
},
{
"@type": "Question",
"name": "Quels sont les effets des thérapies complémentaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les thérapies complémentaires peuvent aider à gérer le stress et améliorer le bien-être général."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec ces troubles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des chutes, des blessures et des troubles de la déglutition."
}
},
{
"@type": "Question",
"name": "Les troubles cognitifs sont-ils une complication fréquente ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles cognitifs peuvent survenir, affectant la mémoire et la concentration."
}
},
{
"@type": "Question",
"name": "Comment les troubles de la marche peuvent-ils affecter la vie quotidienne ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent limiter l'autonomie et augmenter le risque de chutes et d'accidents."
}
},
{
"@type": "Question",
"name": "Les complications psychologiques sont-elles possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications comme l'anxiété et la dépression peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent réduire la qualité de vie en limitant les activités quotidiennes."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les troubles des noyaux gris centraux ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, des antécédents familiaux et certaines maladies neurologiques."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les traumatismes crâniens sont-ils un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traumatismes crâniens peuvent augmenter le risque de troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes peuvent-elles jouer un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent affecter les noyaux gris centraux."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines est-elle un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certaines toxines environnementales peut augmenter le risque."
}
}
]
}
]
}
During the COVID-19 epidemic, face-to-face mental health services faced obstacles. Using Internet-based interventions was a good solution and had the potential to overcome these treatment barriers. Ho...
Although most survivors of breast cancer report substantial sexual concerns following treatment, few receive support for these concerns. Delivering sexual health care to survivors of breast cancer via...
Guided by the multiphase optimization strategy methodological framework, the primary objective of this study is to identify the most efficient internet-delivered sexual health intervention package tha...
Partnered, posttreatment adult female survivors of breast cancer (N=320) experiencing at least 1 bothersome sexual symptom (ie, pain with sex, vaginal dryness, low sexual desire, and difficulty with o...
This protocol has been reviewed and approved by the National Cancer Institute Central Institutional Review Board. Data collection is planned to begin in March 2024 and conclude in 2027....
By identifying the combination of the fewest and least-intensive intervention components likely to provide survivors of breast cancer the greatest sexual health benefit, this study will result in the ...
ClinicalTrials.gov NCT06216574; https://clinicaltrials.gov/study/NCT06216574....
PRR1-10.2196/57781....
In Germany, the prevalence rates for alcohol use disorders amount to approx. 6%, while about 3% are diagnosed as being alcohol dependent. Only 10% of the patients are undergoing treatment. There are a...
Over a 4-week period, 4 different channels of OAmN posted announcements for a survey participation introducing a link leading to a web-based survey questionnaire on the domain oamn.jetzt. The question...
Out of 2022 participants 84.3% (n = 1705) stated to have or have had a problem with alcohol use, 17.7% (n = 302) had a diagnosis of alcohol dependence by a physician or psychologist and only 21% (n = ...
This pilot study revealed that OAmN can reach people affected by problematic drinking behavior who had not been in contact with the professional medical system for addiction treatment despite having a...
Whether Internet of Things (IoT)-based home respiratory muscle training (RMT) benefits patients with comorbid chronic obstructive pulmonary disease (COPD) remains unclear. Therefore, this study aims t...
Seventy-eight patients with stable COPD were randomly divided into two groups. The control group received routine health education, while the intervention group received IoT-based home RMT (30 inspira...
Seventy-four patients with COPD were analyzed (intervention group = 38, control group = 36), and the mean age and FEV...
Compared with no intervention, IoT-based home RMT may be a more beneficial intervention for patients with COPD....
Persistent somatic symptoms of varying etiology are very common in emerging adults and can lead to distress and impairment. Internet-delivered interventions could help to prevent the burden and chroni...
Signposting to web-based interventions is becoming increasingly popular in primary care. Most resources are focused on individuals with clinical problems, but less is known about the uptake of general...
To describe participant and practice characteristics associated with the use of a web-based psychoeducational intervention. Eligible participants were pregnant women presenting at their first antenata...
The study was nested in a cluster randomised trial of resilientchild.dk. We conducted a relative importance analysis, which allows for determination of the variables most strongly associated with webs...
Parity and the absence of a nurse or midwife in the practice were important factors driving a decrease in the likelihood of using resilientchild.dk. Being a student or living outside the capital city ...
The data offer unique opportunities to assess the utilisation of a web-based mental health-promotion intervention following advice from a clinician. This study draws conclusions about which patients a...
Registered in clinicaltrials.gov, Trial number: NCT04129359 Date of registration: 16/10/2019 ( https://clinicaltrials.gov/ct2/show/NCT04129359 )....
Cancer has emerged as a considerable global health concern, contributing substantially to both morbidity and mortality. Recognizing the urgent need to enhance the overall well-being and quality of lif...
This study evaluates the effectiveness of online MBIs, encompassing both app- and website-based MBIs, for patients with cancer and provides insights into the potential implementation and sustainabilit...
Searches were conducted across 8 electronic databases, including the Cochrane Library, Web of Science, PubMed, Embase, SinoMed, CINAHL Complete, Scopus, and PsycINFO, until December 30, 2022. Randomiz...
Among 4349 articles screened, 15 (0.34%) were included. The total population comprised 1613 participants, of which 870 (53.9%) were in the experimental conditions and 743 (46.1%) were in the control c...
App- and website-based MBIs show promise for improving mental health and QOL outcomes in patients with cancer, and further research is needed to optimize and customize these interventions for individu...
PROSPERO CRD42022382219; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=382219....
Insomnia is a highly prevalent sleep disorder frequently comorbid with mental health conditions in nurses. Despite the effectiveness of evidence-based cognitive behavioral therapy for insomnia (CBT-I)...
The hypothesis was that the IMBSR would be noninferior to the ICBT-I in reducing the severity of insomnia among nurses with insomnia. Additionally, it was expected that ICBT-I would produce a greater ...
Among 240 screened nurses, 134 with insomnia were randomly allocated (IMBSR,...
The retention rate was 55% with 77.6% (...
Overall, nurses demonstrated high levels of satisfaction and adherence to both interventions. The IMBSR significantly reduced insomnia severity and depression, but the findings of this study do not pr...
Adolescents are advised to sleep 8-10 hours per night; however, most do not sleep for this recommended amount. Poor adolescent sleep is associated with detrimental health outcomes, including reduced p...
The main objective of this study was to determine the acceptability, feasibility, and preliminary impact of a web-based person-based sleep intervention (SleepWise) on adolescent sleep quality. Partici...
A feasibility trial was conducted to test the feasibility, acceptability, and preliminary impact of SleepWise on adolescent sleep quality, developed based on the person-based approach to intervention ...
Participants in both trials reported high levels of acceptability (trial 1: mean 21.00, SD 2.74; trial 2: mean 20.82, SD 2.48) and demonstrated similar levels of engagement with SleepWise. Participant...
SleepWise is an acceptable and potentially efficacious web-based sleep intervention aimed at adolescents. Findings from this study showed that incentivization did not greatly impact engagement, accept...
OSF Registries osf.io/yanb2; https://osf.io/yanb2....
Internet-based cognitive behavioral therapy (iCBT) shows promise in the prevention of depression. However, the specific iCBT components that contribute to its effectiveness remain unclear....
We aim to evaluate the effects of iCBT components in preventing depression among university students....
Using a smartphone cognitive behavioral therapy (CBT) app, we randomly allocated university students to the presence or absence of 5 different iCBT components: self-monitoring, behavioral activation, ...
During the 12-month follow-up, 133 of 1301 (10.22%) participants reported the onset of an MDE. There were no significant differences in the incidence of MDEs between the groups with or without each co...
In this study, we could not identify any specific iCBT components that were effective in preventing depression or the acquisition of CBT skills over the 12-month follow-up period, but all participants...